Toolrite appoints sales director

Steve Gannon takes newly formed position

Pharmaceutical engineering specialist Toolrite, based in Brentwood, UK, has appointed Steve Gannon to the position of sales director.

With more than 30 years’ experience in technical support and then sales in the cosmetics, toiletries and pharmaceutical packaging industries, Gannon joins Toolrite from German pharmaceutical organisation Uhlmann, where he held the role of sales manager for 10 years.

Gaining an HND in Mechanical & Production Engineering, Gannon further strengthened his technical expertise as sales engineer with Uhlmann agent, Ultrapac.

You may also like

Packaging

SGD Pharma acquires Alphial Srl in a strategic step forward

SGD Pharma is pleased to announce an agreement with Italian Private Equity firm Entangled Capital to acquire Alphial Srl, a leading producer of tubular vials and ampoules headquartered in Italy
Manufacturing

Sovereign demonstrates turnkey bottle labelling solution at PPMA Total Show 2025

Integrated labelling and tamper-proofing technologies showcased for high-speed production lines
Manufacturing

Vapourtec unveils compact benchtop peptide synthesiser

Peptide-Builder uses VBFR technology to improve efficiency and reduce waste
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

Pharma outsourcing trends 2025: partnership, precision and resilience

The Bachem team shares its insights on the evolving relationship between pharma companies and CDMOs
Manufacturing

When the chemistry is right: Vetter expands capacities with a pure water generator from Pharmatec

The production of injectable active pharmaceutical ingredients (APIs) is a highly complex process that leaves no room for error
Manufacturing

Complete security with the REACTEX range of lids and lid accessories

The mechanical seal is suitable for use with 10 mm shafts of any material with product contacting parts of borosilicate glass 3.3, FFKM and PTFE
Manufacturing

Genentech and Roche break ground on a state-of-the-art manufacturing facility in Holly Springs, NC, US

The facility will create more than 1900 jobs and support the production of next-generation metabolic medicines, including treatments for obesity
Subscribe now